Che Ping Cheng

535 total citations
28 papers, 419 citations indexed

About

Che Ping Cheng is a scholar working on Molecular Biology, Cardiology and Cardiovascular Medicine and Physiology. According to data from OpenAlex, Che Ping Cheng has authored 28 papers receiving a total of 419 indexed citations (citations by other indexed papers that have themselves been cited), including 18 papers in Molecular Biology, 17 papers in Cardiology and Cardiovascular Medicine and 5 papers in Physiology. Recurrent topics in Che Ping Cheng's work include Receptor Mechanisms and Signaling (12 papers), Renin-Angiotensin System Studies (10 papers) and Cardiovascular Function and Risk Factors (6 papers). Che Ping Cheng is often cited by papers focused on Receptor Mechanisms and Signaling (12 papers), Renin-Angiotensin System Studies (10 papers) and Cardiovascular Function and Risk Factors (6 papers). Che Ping Cheng collaborates with scholars based in United States, China and Italy. Che Ping Cheng's co-authors include Dalane W. Kitzman, George E. Taffet, Bharathi Upadhya, Carlos M. Ferrario, Leanne Groban, Sarfaraz Ahmad, Heng-Jie Cheng, Hao Wang, Jasmina Varagić and Louis J. Dell’Italia and has published in prestigious journals such as Circulation, Circulation Research and Journal of Pharmacology and Experimental Therapeutics.

In The Last Decade

Che Ping Cheng

27 papers receiving 416 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Che Ping Cheng United States 12 254 159 89 49 43 28 419
Valeria Burghi Argentina 11 192 0.8× 129 0.8× 116 1.3× 70 1.4× 33 0.8× 14 350
Ulises Novoa Chile 11 249 1.0× 178 1.1× 139 1.6× 55 1.1× 24 0.6× 21 460
Maria Claudina Camargo de Andrade Brazil 12 167 0.7× 146 0.9× 114 1.3× 20 0.4× 32 0.7× 22 351
Nicholas J. Edmunds United Kingdom 11 140 0.6× 224 1.4× 54 0.6× 80 1.6× 31 0.7× 13 451
Atsushi Shiota Japan 9 368 1.4× 115 0.7× 192 2.2× 41 0.8× 39 0.9× 13 546
Brit Rentzsch Germany 5 268 1.1× 132 0.8× 170 1.9× 15 0.3× 22 0.5× 6 357
Weijian Shao United States 13 252 1.0× 204 1.3× 190 2.1× 40 0.8× 12 0.3× 20 507
Y M Pinto Netherlands 9 342 1.3× 104 0.7× 141 1.6× 61 1.2× 13 0.3× 22 435
Corinne C. Widmer Switzerland 10 71 0.3× 74 0.5× 24 0.3× 88 1.8× 37 0.9× 24 297
Anna Bar Poland 12 122 0.5× 100 0.6× 41 0.5× 98 2.0× 44 1.0× 27 376

Countries citing papers authored by Che Ping Cheng

Since Specialization
Citations

This map shows the geographic impact of Che Ping Cheng's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Che Ping Cheng with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Che Ping Cheng more than expected).

Fields of papers citing papers by Che Ping Cheng

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Che Ping Cheng. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Che Ping Cheng. The network helps show where Che Ping Cheng may publish in the future.

Co-authorship network of co-authors of Che Ping Cheng

This figure shows the co-authorship network connecting the top 25 collaborators of Che Ping Cheng. A scholar is included among the top collaborators of Che Ping Cheng based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Che Ping Cheng. Che Ping Cheng is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Chen, Zhe, Zhi Zhang, Xiaoqiang Sun, et al.. (2025). Enhanced negative modulation of urotensin II on cardiac function and [Ca2+]i regulation in a diabetic rat model: Insights into molecular and cellular mechanisms. Journal of Pharmacology and Experimental Therapeutics. 392(6). 103594–103594. 1 indexed citations
2.
Sun, Xiaoqiang, Jing Cao, Zhe Chen, et al.. (2023). Increased CaMKII activation and contrast changes of cardiac β1-and β3-Adrenergic signaling pathways in a humanized angiotensinogen model of hypertension. Heliyon. 9(7). e17851–e17851. 1 indexed citations
3.
Mikhailov, Alexei, Yixi Liu, Heng-Jie Cheng, Jen‐Jar Lin, & Che Ping Cheng. (2022). Calmodulin-dependent protein kinase II activation promotes kidney mesangial expansion in streptozotocin-induced diabetic mice. Heliyon. 8(11). e11653–e11653. 3 indexed citations
4.
Zhang, Xiaowei, Tiankai Li, Heng-Jie Cheng, et al.. (2021). Chronic GPR30 agonist therapy causes restoration of normal cardiac functional performance in a male mouse model of progressive heart failure: Insights into cellular mechanisms. Life Sciences. 285. 119955–119955. 10 indexed citations
5.
Groban, Leanne, Quang‐Kim Tran, Carlos M. Ferrario, et al.. (2020). Female Heart Health: Is GPER the Missing Link?. Frontiers in Endocrinology. 10. 919–919. 38 indexed citations
6.
Ferrario, Carlos M., Leanne Groban, Hao Wang, et al.. (2020). The Angiotensin-(1–12)/Chymase axis as an alternate component of the tissue renin angiotensin system. Molecular and Cellular Endocrinology. 529. 111119–111119. 12 indexed citations
7.
Cheng, Heng-Jie, Yixi Liu, Xiaoqiang Sun, et al.. (2019). Abstract 10275: The Role and Mechanism of Chronic Ca2+/Calmodulin-Dependent Protein Kinase II Inhibition in a Mouse Model of Diabetic Cardiomyopathy. Circulation. 1 indexed citations
8.
Cheng, Heng-Jie, Yixi Liu, Zhe Chen, et al.. (2019). Abstract 10246: Chronic Beta3-Adrenergic Receptor Antagonist Therapy Rescues Diabetic Cardiomyopathy Through Ca2+/Calmodulin-Dependent Protein Kinase II Inhibition. Circulation. 1 indexed citations
9.
Ferrario, Carlos M., Jessica L. VonCannon, Sarfaraz Ahmad, et al.. (2019). Activation of the Human Angiotensin-(1-12)-Chymase Pathway in Rats With Human Angiotensinogen Gene Transcripts. Frontiers in Cardiovascular Medicine. 6. 163–163. 16 indexed citations
10.
Li, Tiankai, Zhi Zhang, Xiaowei Zhang, et al.. (2019). Reversal of angiotensin-(1–12)-caused positive modulation on left ventricular contractile performance in heart failure: Assessment by pressure-volume analysis. International Journal of Cardiology. 301. 135–141. 8 indexed citations
11.
Reyes, Santiago, Che Ping Cheng, Tomohisa Yamashita, et al.. (2019). Angiotensin-(1–12)/chymase axis modulates cardiomyocyte L-type calcium currents in rats expressing human angiotensinogen. International Journal of Cardiology. 297. 104–110. 8 indexed citations
12.
Liu, Yixi, Heng-Jie Cheng, Zhe Chen, et al.. (2018). Abstract 11399: Chronic Ca2+/Calmodulin-Dependent Protein Kinase II Inhibition Causes Regression in a Mouse Model of Diabetic Cardiomyopathy: Insights Into Molecular and Cellular Mechanisms. Circulation. 1 indexed citations
13.
Li, Tiankai, Xiaowei Zhang, Heng-Jie Cheng, et al.. (2018). Critical role of the chymase/angiotensin-(1–12) axis in modulating cardiomyocyte contractility. International Journal of Cardiology. 264. 137–144. 13 indexed citations
14.
Zhang, Xiaowei, Heng-Jie Cheng, Dalane W. Kitzman, et al.. (2017). Cellular basis of angiotensin-(1-7)-induced augmentation of left ventricular functional performance in heart failure. International Journal of Cardiology. 236. 405–412. 25 indexed citations
15.
Reyes, Santiago, Jasmina Varagić, Sarfaraz Ahmad, et al.. (2017). Novel Cardiac Intracrine Mechanisms Based on Ang-(1-12)/Chymase Axis Require a Revision of Therapeutic Approaches in Human Heart Disease. Current Hypertension Reports. 19(2). 16–16. 29 indexed citations
16.
17.
Ferrario, Carlos M., Sarfaraz Ahmad, Jasmina Varagić, et al.. (2016). Intracrine angiotensin II functions originate from noncanonical pathways in the human heart. American Journal of Physiology-Heart and Circulatory Physiology. 311(2). H404–H414. 48 indexed citations
18.
Cheng, Heng-Jie, et al.. (2015). Overexpression myocardial inducible nitric oxide synthase exacerbates cardiac dysfunction and beta-adrenergic desensitization in experimental hypothyroidism. International Journal of Cardiology. 204. 229–241. 18 indexed citations
19.
Upadhya, Bharathi, George E. Taffet, Che Ping Cheng, & Dalane W. Kitzman. (2015). Heart failure with preserved ejection fraction in the elderly: scope of the problem. Journal of Molecular and Cellular Cardiology. 83. 73–87. 120 indexed citations
20.
Hinsdale, Mark E., et al.. (2001). Analysis of glutathione by capillary electrophoresis based on sample stacking. Electrophoresis. 22(11). 2351–2354. 26 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Valeria Burghi Breakdown of academic impact, for papers by Ulises Novoa Breakdown of academic impact, for papers by Maria Claudina Camargo de Andrade Breakdown of academic impact, for papers by Nicholas J. Edmunds Breakdown of academic impact, for papers by Atsushi Shiota Breakdown of academic impact, for papers by Brit Rentzsch Breakdown of academic impact, for papers by Weijian Shao Breakdown of academic impact, for papers by Y M Pinto Breakdown of academic impact, for papers by Corinne C. Widmer Breakdown of academic impact, for papers by Anna Bar
Rankless by CCL
2026